Ventas Earnings: Despite Small Occupancy Decline, Senior Housing Drives Total Company Growth
Ventas VTR reported second-quarter results that were slightly below our expectations, though we didn’t see anything in the quarter that would materially change our $68 fair value estimate. Same-store occupancy for the senior housing portfolio declined 10 basis points sequentially to 81.3% in the second quarter, below our estimate of a 90-basis-point sequential gain. Senior housing rental rates increased 6.6% year over year, in line with our estimate of 6.4% growth. Same-store operating expenses were only up 3.7%, leading to margins improving 160 basis points to 25.4% and same-store net operating income growing 14.0%, though that is slightly below our estimate of 16.0% growth. In the second quarter, same-store NOI grew 2.0% for the triple-net senior housing segment, 3.8% for the medical office segment, and 3.8% for the life science segment. Combined, Ventas reported total company same-store NOI growth of 7.0% in the second quarter, which was slightly below our estimate of 7.4% growth. As a result, normalized funds from operations grew 4.5% to $0.75 per share, though that came in $0.03 below our $0.78 estimate for the quarter.
Management provided an update on senior housing demand and supply growth. Similar to our own forecasts, management anticipates that demand growth for senior housing will be 2 times higher over the next four years compared with the prior economic cycle and then will double again over the four-year period. Meanwhile, Ventas said construction as a percentage of overall inventory is at its lowest level since 2011, with the national senior housing construction pipeline at just 4.6% of inventory, while the construction pipeline in Ventas’ markets is at 3.2% of inventory. These figures reinforce our prediction that occupancy and thus NOI for the senior housing industry will see significant growth over the next several years.
The author or authors do not own shares in any securities mentioned in this article. Find out about Morningstar’s editorial policies.